This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Metastatic Colorectal Cancer: Applying Evidence-based Recommendations for Evaluation and Management

Metastatic Colorectal Cancer: Applying Evidence-based Recommendations for Evaluation and Management

Format

Webcast

Time to Complete

1 hour

Released

February 6, 2018

Expires

February 6, 2019
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM
0.80 / CNE Contact Hour (0.40 pharmacotherapy credit)

Accredited Provider

Jointly Provided by Postgraduate Institute for Medicine and MCM Education.

Commercial Supporter

This activity is supported by an independent educational grant from Bayer Healthcare Pharmaceuticals, Inc.

Program Description

Colorectal cancer is the third most common cancer in men and women. Current evidence-based guidelines recommend that all metastatic colorectal tumors be tested for RAS mutations (both KRAS and NRAS) and BRAF mutations, as the presence of such mutations has implications for treatment. Clinical practice is variable, however, and many patients do not receive guideline-based care. This activity will examine optimal management of metastatic colorectal cancer.

Intended Audience

This activity is intended for medical oncologists, radiation oncologists, surgical oncologists, pathologists, oncology NPs and PAs, oncology nurses, and other healthcare providers engaged in the care of patients with colorectal cancer.

Educational Objectives

Upon completion of this educational activity, participants should be able to:

  • Discuss the clinical relevance of extended RAS analysis at diagnosis and first relapse, BRAF testing, and MSI testing during workup for mCRC patients
  • Apply the most current evidence-based clinical practice guidelines to the management of patients with mCRC
  • Describe a multidisciplinary team approach to the management of mCRC involving surgery, radiation, and other treatment modalities
  • Review efficacy and safety data from clinical trials of approved agents being investigated for new indications in mCRC and for emerging investigational agents for the management of mCRC

Conflict Of Interest Disclosure Policy

The Postgraduate Institute for Medicine requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty

Wells A. Messersmith, MD, FACP
Professor of Medicine
Head, Division of Medical Oncology
Program Co-Leader, Developmental Therapeutics
University of Colorado Cancer Center
University of Colorado School of Medicine
Aurora, CO

Dr. Messersmith has disclosed the following:
Contracted Research: Pfizer, Roche/Genentech, Takeda

Accredited Provider Disclosures

The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP, have nothing to disclose.

Publishing Staff disclosures

The MCM Education planners and managers have nothing to disclose.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and MCM Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

0.80

Type

CNE Contact Hour(s)

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and MCM Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.80 contact hours. Designated for 0.40 pharmacotherapy contact hours for Advance Practice Registered Nurses.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities

Instructions

In order to receive credit, participants must complete the pre-assessment questions, post-test, and program evaluation. Participants must also score at least 80% on the posttest. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

For information about the accreditation of this program, please contact Postgraduate Institute for Medicine at: information@pimed.com or (303) 799-1930.

Privacy Policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue